346 results on '"Haramburu, Françoise"'
Search Results
2. Usages de substances de synthèse en France et en Europe
3. Identifying Drugs Inducing Prematurity by Mining Claims Data with High-Dimensional Confounder Score Strategies
4. Du médicament psychoactif à l’addictovigilance dans le Code de la santé publique en France (1990–2017)
5. Analgesic switching in chronic users of dextropropoxyphene in France.
6. Consommation de substances psychoactives à la Réunion et à Mayotte, départements français de l’Océan Indien
7. Parachuting psychoactive substances: Pharmacokinetic clues for harm reduction
8. Imputabilité en pharmacovigilance : de la méthode française originelle aux méthodes réactualisées
9. Causality assessment in pharmacovigilance: The French method and its successive updates
10. Validation and Reproducibility of the Updated French Causality Assessment Method: an Evaluation by Pharmacovigilance Centres & Pharmaceutical Companies
11. Drugs and Sleep Apneas? A review of the French Pharmacovigilance database
12. Comment identifier un signal en addictovigilance ?
13. Signal Identification in Addictovigilance: the Functioning of the French System
14. Impact of Medicine Withdrawal on Reporting of Adverse Events Involving Therapeutic Alternatives: A Study from the French Spontaneous Reporting Database
15. Statins in pregnancy
16. Comment le grand public utilise Internet pour rechercher des informations sur le médicament ?
17. Updating the French Method for the Causality Assessment of Adverse Drug Reactions
18. Which psychoactive substances are used by patients seen in the healthcare system in French overseas territories? Results of the OPPIDUM survey
19. An updated method improved the assessment of adverse drug reaction in routine pharmacovigilance
20. Preventability of adverse effects of analgesics: analysis of spontaneous reports
21. La mise en place des cohortes en France : pourquoi, pour qui, comment et avec quels moyens ?
22. Réactualisation de la méthode française d’imputabilité des effets indésirables des médicaments
23. Illicit drugs or medicines taken by parachuting
24. Adverse drug reactions induced by cotrimoxazole: still a lot of preventable harm
25. Admissions to Hospital Caused by Adverse Drug Reactions: Cross Sectional Incidence Study
26. Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study
27. Pharmacovigilance Systems in Developing Countries: An Evaluative Case Study in Burkina Faso
28. Effect of Competition Bias in Safety Signal Generation: Analysis of a Research Database of Spontaneous Reports in France
29. Early Detection of Pharmacovigilance Signals with Automated Methods Based on False Discovery Rates: A Comparative Study
30. Implementation of an automated signal detection method in the French pharmacovigilance database: a feasibility study
31. Fluindione and drug reaction with eosinophilia and systemic symptoms: an unrecognised adverse effect?
32. Sources of Information on Lymphoma Associated with Anti-Tumour Necrosis Factor Agents: Comparison of Published Case Reports and Cases Reported to the French Pharmacovigilance System
33. Relevance of a “Dear Doctor letter” to alert healthcare providers to new recommendations for vitamin D administration
34. Génériques et modalités de substituabilité : propositions de méthodes pour évaluer l’équivalence, la traçabilité et le relevé de Pharmacovigilance
35. Generics and Substitution Modalities: Proposed Methods for the Evaluation of Equivalence, Traceability and Pharmacovigilance Reporting
36. Premières journées nationales de pharmacodépendance (CEIP). Place de la pharmacodépendance dans l’évaluation du médicament
37. Comparison of Three Methods (Consensual Expert Judgement), (Algorithmic and Probabilistic Approaches) of Causality Assessment of Adverse Drug Reactions: An Assessment Using Reports Made to a French Pharmacovigilance Centre
38. Cutaneous Adverse Effects of Ketoprofen for Topical Use: Clinical Patterns and Costs
39. Factors Associated with Serious Adverse Reactions to Cholinesterase Inhibitors: A Study of Spontaneous Reporting
40. Pilot evaluation of an automated method to decrease false-positive signals induced by co-prescriptions in spontaneous reporting databases†
41. Inhaled Corticosteroids and Adrenal Insufficiency: Prevalence and Clinical Presentation
42. Anciens utilisateurs chroniques de dextropropoxyphène : évolution de leurs délivrances d’antalgiques après l’arrêt de sa commercialisation en France
43. Life-threatening adverse drug reactions at admission to medical intensive care: a prospective study in a teaching hospital
44. Impact of Safety Alerts on Measures of Disproportionality in Spontaneous Reporting Databases The Notoriety Bias
45. Pharmaceutical market of analgesic medicines in Romania
46. Quelle pharmacovigilance pour les vaccins ?
47. Which Pharmacovigilance for Vaccines?
48. Les médicaments orphelins commercialisés en France (2001-2005) : information officielle et spécificités
49. Surveillance of adverse effects during a vaccination campaign against meningitis C
50. Trends in Spontaneous Adverse Drug Reaction Reports to the French Pharmacovigilance System (1986—2001)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.